Disabetes drug Ozempic now popular as a weight-loss drug
Ozempic and related GLP-1 drugs have taken Europe and North America by storm and have quickly become the darling of the ...
Without immediate action, nearly 260 million people in the US predicted to be overweight or obese by 2050
Over the past three decades, there has been a startling increase in the prevalence of obesity across the U.S., at least ...
GLP-1 RA use tied to lower rate of venous thromboembolism in diabetes
For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...